Ming Yan Sells 20,000 Shares of Cytek Biosciences, Inc (NASDAQ:CTKB) Stock theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Cytek Biosciences (NASDAQ:CTKB – Free Report) had its price objective trimmed by Morgan Stanley from $8.00 to $7.00 in a research report released on Thursday morning, Benzinga reports. The firm currently has an equal weight rating on the stock. Several other equities analysts have also commented on CTKB. Raymond James initiated coverage on Cytek Biosciences […]
The move reflects a similar trend globally where countries are stepping up their scrutiny of investments to protect critical industries. Read more at straitstimes.com.
Hhlr Advisors LTD. reduced its stake in shares of Cytek Biosciences, Inc. (NASDAQ:CTKB – Free Report) by 11.3% in the first quarter, according to its most recent filing with the SEC. The fund owned 7,703,514 shares of the company’s stock after selling 981,016 shares during the period. Cytek Biosciences makes up 1.3% of Hhlr Advisors […]